noshorthere
2 months ago
You're right. IF they get current on Q1 (which is now almost 5 months late) and Q2 (which is almost 2 months late) they could get to Pink Status. Then probably get back to OTVQB status. The stock price will follow any good news that is REAL. As Dr Phil is wont to say, “The best predictor of future behavior is relevant past behavior”. Remember, the Company has not only averaged about $2M revenue annually, for the last 20 years, but has not generated 1 penny profit in those 20 years. He (Ric, the Zoologist) embarked on a business strategy, about 20 years ago, of building and selling high-tech capital equipment----without a direct sales force. He acquired Barofold, a high-tech capital equipment maker 7 years ago----still no direct sales force. He started selling the "big guns" (UST) five years ago with, you guessed it, no sales force. He priced his bench-top K45 Baroshear at $200K each plus license fee and ongoing royalties when all the adequate competitors are less than $50K each and no license fees or royalties. He pivoted to tolling a few years ago, then to CBD when tolling that didn't work. He promised up-listing to NASDAQ every year starting in 2017.
He promised to get on NASDAQ by end of year---every year---since 2016, and never did. All their years of Earth-rotation-reversing Press Releases (Agrochem, Barofold, Dr Denise, tolling, Safer Medical of Montana, Cannaworx, Not one thing that these baffoons have PR'd, or done, for years has ever come to fruition.
Oh, yeah, as far as him issuing PRs goes----he issues a PR every time he passes gas, sneezes, or burps. If Uncle Bud's would have shown anything real in the 8 months since they acquired them---they would have PR'd the crap out of it by now. But----silence.
noshorthere
3 months ago
Yes. They are only on OTC Expert Markets because of their failure to file their 10Q with SEC. For all intents and purposes it is nearly impossible to trade the shares while in Expert Markets. Shortly after they get current on their filings they will move up to "Pinks", and then some time later, if they stay current, they will get back to OTCQB.
Now, their real reason for not filing is not known. They claim their auditors, who are in Houston lost power. But 10Qs do not need to be audited, and the auditors have been fined $400K for crappy QC. They have been promising that their Uncle Bud's acquisition was going to take them to the moon. If so, why didn't they put out the 10Q in time?
Oh, yeah, they only generate around $2M annual revenue, so they pay their bills with discounted restricted common shares (that's where the constant share dilution comes from) so the cash can be used to pay their salaries. Schumacher is CEO and gets $400K/yr, and his wife is the COO, but I can't find what her take is. With a company of only around 20 employees those two are both grossly overpaid. Will they succeed? Who knows? they don't produce anything themselves, They haven't ever made a profit in at least 27 years. And they do not have a sales force. All they seem to have is a golden story that resonates with gamblers.
noshorthere
6 months ago
You believe that the Company tells the truth? Righteous Ric, the friggin' Zoologist CEO, told everybody to wait till the 17th to vote because of upcoming good news. The meeting "in lieu of" the annual shareholders meeting was on the 18th. The meeting was for elections on 4 issues---retaining Schumacher as CEO, and the compensation plans. The SEC says that annual reports should be out prior to the Proxy Statements and elections. HMMMM! There has been a never ending series of BS Press Releases that NEVER prove true---remember Agrochem, how about Tolling, THC Licenses with ongoing royalties. They lie about their competition's capabilities. They lie about customer interest. They constantly lied about upcoming revenue. They've lied for years about up-listing to NASDAQ by years end. They are constantly doing business pivots (unsuccessfully). By the way, you do know that Schumacher's wife is the Controller, don't you?
“It's easier to fool people than to convince them that they have been fooled.” ….Mark Twain
noshorthere
6 months ago
It's in the 8K filed on the 22nd:
Nominee For Against Withhold Broker Non-Votes
Richard T. Schumacher 7,109,810 1,638,664 533,157 6,242,303
Proposal 2 - Ratify the appointment of MaloneBailey LLP as the Company’s independent auditor for fiscal year 2023. The ratification of the appointment of MaloneBailey LLP as the Company’s independent auditor for fiscal year 2023 was approved as follows:
Shares voted
For 13,900,704
Against 787,086
Abstain 836,144
Broker Non-Votes 0
Proposal 3 – Approve the Pressure BioSciences, Inc. 2024 Equity Incentive Plan. The Pressure BioSciences, Inc. 2024 Equity Incentive Plan was approved as follows:
Shares voted
For 6,474,213
Against 2,696,003
Abstain 111,415
Broker Non-Votes 6,242,303
Proposal 4 – Approval, on an advisory basis, of a non-binding resolution to approve the compensation of our named executive officers. The non-binding resolution was approved as follows:
Shares voted
For 5,961,481
Against 2,337,936
Abstain 982,214
Broker Non-Votes 6,242,303
noshorthere
6 months ago
Let's all remember that this is an OTC stock, and 90% of OTC companies fail. No one "invests" in OTC companies---they gamble on OTC companies. You know, like paying Power Ball or heading for the roulette wheel when you walk into a casino. If you are into an OTC stock you are 90% likely to fail. If you don't do exhaustive research, or understand the technology you are 99% likely to fail.
“If you know the enemy and know yourself, you need not fear the result of a hundred battles. If you know yourself but not the enemy, for every victory gained you will also suffer a defeat. If you know neither the enemy nor yourself, you will succumb in every battle.” ….SunTzu
🤪
noshorthere
7 months ago
165ºF (with no “pink” parts) – this temperature will kill the H5N1 virus (bird flu) as well as other illnesses.
Pasteurization of milk, widely practiced in several countries, notably the United States, requires temperatures of about 63 °C (145 °F) maintained for 30 minutes or, alternatively, heating to a higher temperature, 72 °C (162 °F), and holding for 15 seconds (and yet higher temperatures for shorter periods of time).
“Ultra-pasteurized” means that the milk is heated to a minimum of 280°F for a minimum of 2 seconds. This temperature and time combination is much more lethal to bacteria, killing virtually all of concern.
I lived in Prague for 3 years, and all the milk was Ultra-pasteurized. Sold in boxes and not refrigerated.
PBIO nano-emulsifiers are not unique---they have many lower cost competitors. They are a product in search of a problem to solve
AveragePenny
9 months ago
$PBIO Pressure BioSciences Announces Closing of Uncle Bud’s Acquisition in All-Stock Transaction, Completing UltraShear Nanoemulsions Forward Integration with World Class Marketing & Sales
https://www.globenewswire.com/news-release/2024/01/22/2813059/11282/en/Pressure-BioSciences-Announces-Closing-of-Uncle-Bud-s-Acquisition-in-All-Stock-Transaction-Completing-UltraShear-Nanoemulsions-Forward-Integration-with-World-Class-Marketing-Sales.html
SOUTH EASTON, Mass., Jan. 22, 2024 (GLOBE NEWSWIRE) -- Pressure BioSciences, Inc. (OTCQB: PBIO) (“PBIO” or the “Company”), a pioneer in the development and distribution of broadly enabling pressure-based instruments, consumables, and specialty process development and testing services across global industries, including nutraceuticals, food and beverage, health and wellness, cosmetics, biotherapeutics, and more, today announced the closing of its acquisition of natural health and wellness leader Uncle Bud’s (“UB”) in an all-stock transaction. Incorporating UB’s 70+ already popular products, 865K member on-line community, existing sales channels online and with leading large retailers, enviable celebrity spokesperson relationships, and invaluable experience building successful consumer products businesses, PBIO will leverage and integrate the Company’s revolutionary UltraShear™ technology (UltraShear™ or UST™) platform for further improved nanoemulsified products that deliver industry-leading speed of action, effective dosing payload delivery, and long-term stability. With these unique product improvement and differentiation capabilities, PBIO intends to redefine the basis of competition in multiple major market sectors, and to become a leading provider of topicals and other consumer products.
Transaction Terms
Under the terms of the transaction, PBIO acquired all assets and assumed selected liabilities of UB. In addition, the parties agreed to an earnout for additional shares of PBIO Common Stock based on the achievement of revenue and pre-tax income results in 2024. Upon closing, all employees of UB became employees of PBIO and UB became the Consumer Products Business Unit of PBIO. More definitive transaction terms will be included in the Company’s upcoming SEC filings.
Significance of the Transaction
The transaction is expected to be immediately accretive and a major accelerator to PBIO’s top line revenue growth.
The combined companies will be ideally positioned to attract new growth investment, rapidly strengthen their balance sheet, accelerate PBIO’s path to profitability in 2024, and catalyze our drive to uplist to NASDAQ/NYSE.
The co-founders/senior management of UB are experts in branding, celebrity spokesperson management, and online and retail multimedia marketing.
UB will rapidly incorporate PBIO’s best-in-class Nano-CBD into their already highly renowned and successful CBD products, for new market breakaway potential!
Senior management of UB and PBIO are already planning a dozen new products that they believe could be formulated and released in 2024, just using PBIO’s existing UltraShear processed Nano CBD.
UB markets and sells many products in the health & wellness area that are unrelated to Hemp and CBD.
UB has an ongoing partnership with multi-Grammy award-winning Toni Braxton as a highly successful marketing ambassador – and Toni has announced that she is excited to continue as a PBIO/UB spokesperson going forward.
UB has been featured, as well as their hemp and CBD products, in an extensive variety of high profile news outlets and magazines online over the past several years: https://www.unclebudshemp.com/press/.
Expected Financial Impact
PBIO’s President and CEO, Richard T. Schumacher, summarized: “This transaction combines the existing momentum and ready market execution power of Uncle Bud’s with the pivotal scientific and product breakthrough of the UltraShear nanoemulsions processing platform for record-setting product performance and long-term stability. In 2024 alone, we are forecasting a 5-fold leap forward in PBIO revenues to over $10 million, but this is only a steppingstone towards revolutionary impact and sales growth that we expect to achieve across the nutraceuticals, cosmeceuticals, skincare, food/beverage, agrochemical, and other major markets in the following years.”
Jeffrey N. Peterson, PBIO’s Chairman, added: “Our Board and leadership team have carefully sought out this strategic combination of Uncle Bud’s marketing skill and power to combine with PBIO’s world class scientific innovation team. Specifically, this positions PBIO with a fast forward integration capability that will allow us to selectively set the timing and drive the pace of revolutionary change across multiple major markets. This rapid growth engine provides a central platform to leverage new growth capital, restructure and strengthen our balance sheet, and complete our drive to uplist to a national stock exchange in 2024.”
AveragePenny
10 months ago
$PBIO Pressure BioSciences Reports New Client Launching Around UltraShear Nanoemulsions Platform with $300,000-plus Product Order
https://www.globenewswire.com/news-release/2024/01/18/2811755/11282/en/Pressure-BioSciences-Reports-New-Client-Launching-Around-UltraShear-Nanoemulsions-Platform-with-300-000-plus-Product-Order.html
SOUTH EASTON, Mass., Jan. 18, 2024 (GLOBE NEWSWIRE) -- Pressure BioSciences, Inc. (OTCQB: PBIO) (“PBIO” or the “Company”), a pioneer in the development and distribution of broadly enabling pressure-based instruments, consumables, and specialty process development and testing services across global industries, including nutraceuticals, food and beverage, health and wellness, cosmetics, and more, announced today the receipt of an Open Order Agreement for the purchase in 2024 of a minimum of 10,000 bottles (over $300,000) of the Company’s Nano-CBD Topical Spray, with an initial product shipment in the coming weeks, from the Company’s west coast manufacturing partner. Subsequent shipments will follow quickly thereafter.
VICAR Holdings, LLC (“VICAR”), the purchaser of this revolutionary Nano-CBD Topical Spray, has recently formed with a central health and wellness mission, focused on the on-line sale of only the highest quality and performance products, featured in a premium “PrescriptionGrade” product line. The company’s website and online store are currently under construction, with the initial PrescriptionGrade products slated for Beta testing in March 2024, and fully launching into sales in Q2 2024. VICAR has proudly announced PBIO’s Nano-CBD Topical Spray will be the first product available through their on-line store. The product will be sold as PrescriptionGrade Nano-CBD.
Manufactured using PBIO’s patented UltraShear™ technology (UltraShear™ or UST™), PrescriptionGrade Nano-CBD is a revolutionary high-performance product providing ultrafast speed of action and unprecedented effectiveness, in a preservative-free, “green/clean” labeled, sterile-filtered and vialed, all plant-based, highly stable topical product design. It is expected to quickly become the compelling natural choice for today’s health and environmentally conscious consumers.
John Hollister, PBIO’s Director of Marketing and Sales, added: “It’s great to come into a New Year with strong momentum. On the heels of our highly strategic Uncle Bud’s announcements over the past week, we see the contract with VICAR Holdings as a clear indication of the great things to come in 2024. Each of these contracts will expand the consumer experience pool, which will help spread the word about the quality and effectiveness of UltraShear-processed CBD. Based on the results in a recent peer-reviewed scientific journal article by Professor ElSohly (University of Mississippi), an acknowledged global natural products expert, we know that PrescriptionGrade Nano-CBD is positioned to become recognized as a top-performing CBD product worldwide – and VICAR customers will soon know this as well.”
Vince Caruso, Managing Member of VICAR Holdings, LLC, said: “Our innovative solution employs PBIO’s revolutionary UltraShear platform, which has been designed to optimize the speed of delivery and absorption of CBD and other oil-soluble nutraceuticals. Through meticulous craftmanship and cutting-edge technology, we elevate our products to “PrescriptionGrade™” standards, ensuring only the highest standards of quality and effectiveness. Our commitment to excellence extends well beyond the all-important formulation, encompassing iconic branding and streamlined order flow systems. With a focus on enhancing health and wellness, our strategy integrates cutting-edge scientific knowledge and professionalism to provide customers with superior tools for helping them achieve a healthier lifestyle.”
Ric Schumacher, President and CEO of PBIO, added: “VICAR has access to over 200,000 monthly website visitors and over 90,000 YouTube subscribers through existing businesses affiliated with Vince and members of his team. VICAR also has exclusive access to multiple billboards in Manhattan as well as thousands of media outlets throughout the U.S. and the world. Their online store will sell only the best of the best in health and wellness products. We are proud that PBIO’s Nano-CBD will be the first product featured on the PrescriptionGrade website and look forward to showcasing many additional PBIO nanoemulsified products during 2024, and beyond.”